For five years, Tomas Salmonson was the chair of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency at a time of unprecedented innovation and challenge. Stepping down as the senior scientific advisor at the Swedish Medical Products Agency, Tomas has an open and frank discussion about how Europe must evolve to address the accelerating demands of innovation.See omnystudio.com/listener for privacy information.
Top comments
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.